FierceBiotechFierceBiotechResearchFierceBiotechITFierceVaccinesFiercePharmaFiercePharmaManufacturing   FierceHealthcare
Syndicate content

Tysabri related Press Releases

BMRI DATA SHOWING TYSABRI PROMOTED REMYELINATION PRESENTED AT THE 61ST ANNUAL MEETING OF THE AMERICAN ACADEMY OF NEUROLOGY

Posted May 1, 2009

BMRI DATA SHOWING TYSABRI PROMOTED REMYELINATION PRESENTED AT THE 61ST ANNUAL MEETING OF THE AMERICAN ACADEMY OF NEUROLOGY Additional data suggests improvement in TYSABRI patients across clinical and

... Read more...

EU Panel Recommends Update For Elan, Biogen's Tysabri Label

Posted September 26, 2008

EU Panel Recommends Update For Elan, Biogen's Tysabri Label ZURICH -(Dow Jones)- European Medicines Agency, an advisory body to the European drugs regulator, said Thursday it recommends an update of... Read more...

TYSABRI® DEMONSTRATES SUSTAINED IMPROVEMENT IN FUNCTIONAL OUTCOMES IN MULTIPLE SCLEROSIS PATIENTS ACCORDING TO NEW POST-HOC ANAL

Posted September 22, 2008

TYSABRI® DEMONSTRATES SUSTAINED IMPROVEMENT IN FUNCTIONAL OUTCOMES IN MULTIPLE SCLEROSIS PATIENTS ACCORDING TO NEW POST-HOC ANALYSIS TYSABRI is the Only Marketed MS Treatment to Show Both... Read more...

First Multiple Myeloma Patient Treated

Posted September 5, 2008

Elan and Biogen Idec Initiate First Clinical Trial of TYSABRI® in Oncology First Multiple Myeloma Patient Treated CAMBRIDGE, Mass. & DUBLIN, Ireland--(BUSINESS WIRE)--Sept. 5, 2008--Elan... Read more...

FDA Updates the Information for Healthcare Professionals Sheet for Tysabri (natalizumab)

Posted August 26, 2008

FDA Updates the Information for Healthcare Professionals Sheet for Tysabri (natalizumab) Information for Healthcare Professionals Natalizumab Injection for Intraveneous Use (marketed as Tysabri)... Read more...